A Duke-led study reports that measuring piRNAs in blood samples predicts two-year survival in older adults with up to 86% accuracy, outperforming traditional health indicators, according to findings published in Aging Cell.
Fewer than 15% of US healthcare organizations have selected a digital pathology vendor, according to a new KLAS report, which also finds higher customer satisfaction with pathology-specific companies.
The FDA has granted Breakthrough Device Designation to Breath Diagnostics Inc.'s OneBreath, a breath-based test that assesses postoperative pneumonia risk in cardiac surgery patients using a single preoperative sample.
The AI companion analyzes up to five years of personal lab data within the company's patient portal to explain test results and identify health trends.
Thermo Fisher Scientific has opened an $18 million, 8,000-square-meter distribution and labeling center in Uppsala, Sweden, to support global supply of immunodiagnostics for allergy and autoimmune disease testing.
